iHuman (IH)
(Delayed Data from NYSE)
$1.55 USD
0.00 (0.00%)
Updated Sep 11, 2024 01:23 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for iHuman Inc Sponsored ADR falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 143 | 143 | 148 | 82 | 31 |
Cost Of Goods | 42 | 43 | 45 | 26 | 12 |
Gross Profit | 102 | 100 | 104 | 56 | 19 |
Selling & Adminstrative & Depr. & Amort Expenses | 79 | 84 | 112 | 63 | 59 |
Income After Depreciation & Amortization | 23 | 16 | -9 | -7 | -39 |
Non-Operating Income | 6 | 3 | 3 | 1 | 1 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 29 | 19 | -6 | -6 | -39 |
Income Taxes | 3 | 3 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 25 | 16 | -6 | -6 | -39 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 25 | 16 | -6 | -6 | -39 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 24 | 18 | -8 | -6 | -39 |
Depreciation & Amortization (Cash Flow) | 2 | 2 | 1 | 0 | 0 |
Income After Depreciation & Amortization | 23 | 16 | -9 | -7 | -39 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 54.75 | 54.04 | 53.33 | 45.27 | NA |
Diluted EPS Before Non-Recurring Items | 0.46 | 0.29 | -0.11 | -0.16 | NA |
Diluted Net EPS (GAAP) | 0.46 | 0.29 | -0.11 | -0.16 | -1.10 |
Fiscal Year end for iHuman Inc Sponsored ADR falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 32.55 | 35.71 | 35.84 | 33.23 |
Cost Of Goods | NA | 9.26 | 10.28 | 10.26 | 9.68 |
Gross Profit | NA | 23.28 | 25.43 | 25.58 | 23.56 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 20.87 | 22.34 | 20.04 | 17.93 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 2.41 | 3.09 | 5.54 | 5.63 |
Non-Operating Income | NA | 1.25 | 1.33 | 2.67 | 1.12 |
Interest Expense | NA | NA | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 3.67 | 4.42 | 8.21 | 6.76 |
Income Taxes | NA | 0.58 | -0.33 | 1.09 | 0.96 |
Minority Interest | NA | NA | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | NA | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | NA | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 3.09 | 4.75 | 7.12 | 5.80 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 3.09 | 4.75 | 7.12 | 5.80 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 54.69 | 54.75 | 54.77 | 54.73 |
Diluted EPS Before Non-Recurring Items | NA | 0.06 | 0.09 | 0.13 | 0.11 |
Diluted Net EPS (GAAP) | NA | 0.06 | 0.08 | 0.13 | 0.11 |